Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Bold Medicine, Golden Innovation

Xenia Kachur, a graduate student in the Biomedical Engineering Graduate Interdisciplinary Program at the University of Arizona, is working on methods to deliver chemotherapeutic drugs to cancer tissues without harming healthy body cells. Photo credit: Beatriz Verdugo/UANews
Xenia Kachur, a graduate student in the Biomedical Engineering Graduate Interdisciplinary Program at the University of Arizona, is working on methods to deliver chemotherapeutic drugs to cancer tissues without harming healthy body cells. Photo credit: Beatriz Verdugo/UANews

Abstract:
One day, building on the bold work being done by Marek Romanowski and his students, those suffering cancer may be able to receive effective chemotherapy treatment, confident that they will not have to endure the side effects. To a patient facing such treatments, such confidence will be as good as gold.

Bold Medicine, Golden Innovation

Tucson, AZ | Posted on January 31st, 2011

The upside of chemotherapy is that it attacks cancer cells and kills them. The downside - and a steep downside it is - is that it is composed of highly toxic compounds that attack other cells of the body, too, resulting in any number of harmful side effects, from anemia to hair loss to nausea and vomiting.

The question concerning researchers is how do we deliver chemotherapy drugs to the harmful cells and leave the healthy cells alone?

Marek Romanowski, Ph.D. associate professor of biomedical engineering at the UA College of Engineering and member of the BIO5 Institute and the Arizona Cancer Center, and his team might be on to an answer. In a paper authored by primary investigator Sarah Leung, along with Xenia Kachur, Michael Bobnick and Dr. Romanowski, Leung describes an idea that is literally golden.

Chemotherapy drugs are sometimes delivered via microscopic capsules called liposomes made of organic lipids already present in cells. These lipid casings, used in a technique called liposomal therapy, do two things. First, they allow the drugs to more effectively penetrate into cancer cells. At the same time, they keep the body's immune system from eliminating the drugs before they can do their jobs.

The problem is that, as the liposomes degrade, the drugs are potentially released indiscriminately throughout the body. So, how can we force these capsules to release their contents only around those unhealthy tumor cells?

Romanowski and his team are experimenting by coating liposomes with gold, an element which has the property of converting infrared light into heat.

"The heat causes the liposome to become leaky, and then whatever's really concentrated inside can diffuse out through the liposome," says Kachur, a third-year graduate student in the Biomedical Engineering Graduate Interdisciplinary Program.

The idea works because infrared light has the ability to penetrate deeply through the body.

"Once you know where the tumors are, you can go ahead and point your light source toward those areas. Whatever else is left will leave the body or may be slowly released, but not to as high or as toxic of levels as it would be if you just injected the drug systemically," said Leung, a fourth-year graduate student.

One last bonus to the proposed innovation is that the kidneys can naturally filter and eliminate the biodegraded gold nanostructures from the body.

If successful, the gold-coated liposomes being developed at the UA could offer a new way to target delivery of drugs to cancerous regions of the body, non-invasively trigger the drugs' release using infrared light, and provide a way for the body to naturally eliminate the toxic byproducts.

One day, building on the bold work being done by Marek Romanowski and his students, those suffering cancer may be able to receive effective chemotherapy treatment, confident that they will not have to endure the side effects. To a patient facing such treatments, such confidence will be as good as gold.

The paper, "Wavelength-selective Light-induced Release from Plasmon Resonant Liposomes," will appear in the journal Advanced Functional Materials. Learn more about the Department of Biomedical Engineering at bme.engr.arizona.edu/.

####

For more information, please click here

Copyright © University of Arizona

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Possible Futures

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Academic/Education

Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016

The University of Applied Sciences in Upper Austria uses Deben tensile stages as an integral part of their computed tomography research and testing facility October 18th, 2016

Enterprise In Space Partners with Sketchfab and 3D Hubs for NewSpace Education October 13th, 2016

New Agricultural Research Center Debuts at UCF October 12th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project